Billings Clinic Press Releases

Billings Clinic is pleased to announce that on Wednesday, March 31, it will move its temporary Viral Triage Unit (VTU) to its new home at SameDay Care, at 801 N. 29th St., on the downtown Billings Clinic campus. Testing and evaluation for COVID-19 and other respiratory illnesses (point of care influenza, strep, etc.) will be conducted in this area, called SameDay Care Viral.

Billings Clinic is pleased to announce that it will establish a new helicopter air ambulance service in Bozeman. This is an expansion of its Billings-based fixed wing MedFlight Air Ambulance service and provides an extension of critical lifesaving transportation consistent with Billings Clinic’s mission.

Billings Clinic is pleased to announce the expansion of orthopedic services and outpatient CT/MRI available in Cody, WY.

Billings Clinic is pleased to announce the completion of its new 2,900 square foot, $863,000 pediatric infusion center in downtown Billings, MT. T

Billings Clinic was designated as a Magnet organization in 2006, 2011, and 2016 by the ANCC Magnet Recognition Program®. This prestigious designation recognizes excellence in nursing services. In March 2021, Billings Clinic is applying for redesignation.

Individuals included in the above groups, are invited to schedule an appointment for COVID-19 vaccinations through either St. Vincent Healthcare or Billings Clinic. No walk-in vaccinations will be given. Patient-facing healthcare personnel and first responders must show valid credentials (proof of healthcare entity employment, employee badge, etc.) at the time of vaccination.

Billings Clinic will administer its first doses of the Pfizer COVID-19 vaccine on Tuesday, December 14, at noon. The first vaccines will go to a team of five people that will be representing every member of the Billings Clinic health system and first responders that have been at the forefront of caring for our rural and urban Montana and Wyoming communities during the COVID-19 pandemic.

Billings Clinic received their first allocations of Bamlanivimab monoclonal antibody (mAb) and Casirivimab/Imdevimab treatment from the Montana Department of Health and Human services to treat COVID-19 patients with mild to moderate illness who meet specific requirements.